DailyDoctor Archive Specialties Get app
Back to the 2 October 2026 edition

Research · 02 of 05

Buccal 50% dextrose raised glucose in hypoglycaemic newborns but did not cut IV dextrose

Where 40% dextrose gel is unavailable, buccal 50% dextrose appears safe but has not been shown to prevent IV treatment.

Design
Multicentre, randomised, double-blind, placebo-controlled
Population
400 neonates ≥34 weeks with persistent asymptomatic hypoglycaemia
Primary outcome
Need for IV dextrose
Effect
4.9% vs 8.7% (p = 0.18)

A double-blind, placebo-controlled trial at two high-risk nurseries in Bangkok randomised 400 at-risk neonates of 34 weeks' gestation or more whose blood glucose stayed below threshold 30 minutes after the first feed. They received buccal 50% dextrose (200 mg/kg, 0.4 mL/kg) or placebo, followed by a feed.

The proportion needing IV dextrose was 4.9% with dextrose and 8.7% with placebo, a difference that was not statistically significant (p = 0.18). Glucose rose more with dextrose (median 28 vs 22.5 mg/dL). No hyperglycaemia, choking, vomiting or mucosal irritation was seen.

Forty per cent dextrose gel is the recommended buccal option but is not always available. This trial suggests a 50% solution is safe and raises glucose, but it did not show the outcome that matters most. The trial may also have been underpowered for a difference of this size.

  • Buccal 50% dextrose raised glucose without observed adverse effects in this trial.
  • It did not significantly reduce IV dextrose use; feeding remains the core intervention.
  • Small- and large-for-gestational-age infants had smaller glucose responses; monitor them closely.
  • Where 40% gel is available, use it as the established buccal option.

Why it matters

Many nurseries lack the recommended gel, and a substitute must be judged on whether it keeps babies with their mothers.

Don't overread it

A non-significant difference in a 400-infant trial is not proof of no effect; the trial may simply have been too small.

The statistics, in plain English

A p-value of 0.18 means a difference this size could plausibly be chance. With few infants needing IV dextrose in either group, the trial had limited power to show a real reduction.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

adolescentneonatalgrowthneurodev

Tomorrow morning, before your first patient

One edition a day for paediatrics, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app